Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | RVTY | HQY | ||
| Company | Charles River Laboratories Intl | Revvity Inc | Healthequity | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 203.42 | 96.97 | 92.30 | ||
| High | 204.19 | 97.09 | 93.70 | ||
| Low | 202.33 | 95.87 | 91.81 | ||
| Latest | 203.66 | 96.75 | 93.48 | ||
| Change | +0.50 | -0.03 | +1.03 | ||
| % Change | +0.25% | -0.03% | +1.11% | ||
| Volume | 293,200 | 557,100 | 490,400 | ||
| 20-Day Average Volume | 699,810 | 1,171,765 | 921,810 | ||
| Previous Close | 203.16 | 96.78 | 92.45 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 191.52 | 99.81 | 96.05 | ||
| 20-Day Raw Stochastic | 97.43% | 12.96% | 17.54% | ||
| 20-Day Relative Strength | 67.57 | 48.84 | 44.09 | ||
| Weighted Alpha | +36.34 | -10.34 | -3.99 | ||
| Today's Opinion | 100% Buy | 56% Buy | 24% Sell | ||
| Previous Opinion | 100% Buy | 56% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Buy | 40% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.06% since 12/18/25 | +0.51% since 12/18/25 | -2.12% since 12/18/25 | ||
| Low | 191.89 on 12/19/25 | 95.49 on 12/19/25 | 91.81 on 12/26/25 | ||
| High | 204.47 on 12/22/25 | 98.55 on 12/22/25 | 97.09 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | +13.81% since 11/26/25 | -7.56% since 11/26/25 | -10.96% since 11/26/25 | ||
| Low | 172.95 on 12/02/25 | 95.44 on 12/16/25 | 90.89 on 12/08/25 | ||
| High | 204.47 on 12/22/25 | 105.55 on 11/28/25 | 105.66 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +37.09% since 09/26/25 | +15.10% since 09/26/25 | -3.16% since 09/26/25 | ||
| Low | 145.47 on 09/29/25 | 83.30 on 09/29/25 | 87.58 on 10/06/25 | ||
| High | 204.47 on 12/22/25 | 106.52 on 11/25/25 | 105.96 on 11/25/25 | ||
| 6-Month | |||||
| %Chg | +34.35% since 06/26/25 | -2.06% since 06/26/25 | -10.85% since 06/26/25 | ||
| Low | 144.26 on 09/25/25 | 81.36 on 09/04/25 | 86.63 on 08/28/25 | ||
| High | 204.47 on 12/22/25 | 106.52 on 11/25/25 | 106.60 on 06/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,023,127 | 10,969,128 | 7,986,557 | ||
| Shares Outstanding, K | 49,215 | 113,376 | 85,436 | ||
| Annual Sales | 4,049,990,000 | 2,755,030,000 | 1,199,770,000 | ||
| Annual Net Income | 22,200,000 | 270,390,000 | 96,700,000 | ||
| Last Quarter Sales | 1,004,850,000 | 698,950,000 | 322,160,000 | ||
| Last Quarter Net Income | 54,420,000 | 46,650,000 | 51,690,000 | ||
| 60-Month Beta | 1.63 | 1.06 | 0.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.43 on 11/05/25 | 1.18 on 10/27/25 | 1.01 on 12/03/25 | ||
| Latest Earnings Date | 02/18/26 | 01/30/26 | 03/17/26 | ||
| Most Recent Dividend | N/A | 0.070 on 10/17/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 01/16/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 19.26 | 20.20 | 29.54 | ||